These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1598098)

  • 21. [Alterations of mitochondria in metabolic diseases. Carnitine deficiency, carnitine palmitoyltransferase deficiency and beta oxidation].
    Angelini C
    Acta Neurol (Napoli); 1989 Oct; 11(5):330-4. PubMed ID: 2603779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical and physiologic consequences of carnitine palmityltransferase deficiency.
    Carroll JE; Brooke MH; DeVivo DC; Kaiser KK; Hagberg JM
    Muscle Nerve; 1978; 1(2):103-10. PubMed ID: 750917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatty acid beta-oxidation in peroxisomes and mitochondria: the first, unequivocal evidence for the involvement of carnitine in shuttling propionyl-CoA from peroxisomes to mitochondria.
    Jakobs BS; Wanders RJ
    Biochem Biophys Res Commun; 1995 Aug; 213(3):1035-41. PubMed ID: 7654220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recruitment of compensatory pathways to sustain oxidative flux with reduced carnitine palmitoyltransferase I activity characterizes inefficiency in energy metabolism in hypertrophied hearts.
    Sorokina N; O'Donnell JM; McKinney RD; Pound KM; Woldegiorgis G; LaNoue KF; Ballal K; Taegtmeyer H; Buttrick PM; Lewandowski ED
    Circulation; 2007 Apr; 115(15):2033-41. PubMed ID: 17404155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Rhabdomyolysis in carnitine palmitoyltransferase deficiency].
    Stavem K; Bjerke G; Skullerud K; Bøhmer T
    Tidsskr Nor Laegeforen; 1994 Aug; 114(20):2398-9. PubMed ID: 7997994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids.
    Akkaoui M; Cohen I; Esnous C; Lenoir V; Sournac M; Girard J; Prip-Buus C
    Biochem J; 2009 May; 420(3):429-38. PubMed ID: 19302064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of carnitine palmitoyltransferase I in skeletal muscle in vivo increases fatty acid oxidation and reduces triacylglycerol esterification.
    Bruce CR; Brolin C; Turner N; Cleasby ME; van der Leij FR; Cooney GJ; Kraegen EW
    Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1231-7. PubMed ID: 17179390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case report of carnitine palmitoyltransferase II deficiency].
    Zhang LX; Gao PM
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Feb; 11(2):1p preceeding I. PubMed ID: 19222961
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical features and new molecular findings in Carnitine Palmitoyltransferase II (CPT II) deficiency.
    Corti S; Bordoni A; Ronchi D; Musumeci O; Aguennouz M; Toscano A; Lamperti C; Bresolin N; Comi GP
    J Neurol Sci; 2008 Mar; 266(1-2):97-103. PubMed ID: 17936304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fatty acid and ketone metabolism.
    Bieber LL; Fiol CJ
    Circulation; 1985 Nov; 72(5 Pt 2):IV9-12. PubMed ID: 4053330
    [No Abstract]   [Full Text] [Related]  

  • 31. Carnitine deficiency disorders in children.
    Stanley CA
    Ann N Y Acad Sci; 2004 Nov; 1033():42-51. PubMed ID: 15591002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trifunctional enzyme deficiency: adult presentation of a usually fatal beta-oxidation defect.
    Schaefer J; Jackson S; Dick DJ; Turnbull DM
    Ann Neurol; 1996 Oct; 40(4):597-602. PubMed ID: 8871579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of carnitine-dependent metabolic pathways in heart disease without primary ischemia.
    Bremer J; Hokland B
    Z Kardiol; 1987; 76 Suppl 5():9-13. PubMed ID: 3324530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperthyroidism facilitates cardiac fatty acid oxidation through altered regulation of cardiac carnitine palmitoyltransferase: studies in vivo and with cardiac myocytes.
    Sugden MC; Priestman DA; Orfali KA; Holness MJ
    Horm Metab Res; 1999 May; 31(5):300-6. PubMed ID: 10422724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lethal neonatal multiorgan deficiency of carnitine palmitoyltransferase II.
    Hug G; Bove KE; Soukup S
    N Engl J Med; 1991 Dec; 325(26):1862-4. PubMed ID: 1961225
    [No Abstract]   [Full Text] [Related]  

  • 36. Recurrent metabolic decompensation in profound carnitine palmitoyltransferase II deficiency.
    Elpeleg ON; Joseph A; Branski D; Christensen E; Holme E; Demaugre F; Saudubray JM; Gutman A
    J Pediatr; 1993 Jun; 122(6):917-9. PubMed ID: 8501570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Kidney tubular transport disorders. Carbonic anhydrase II deficiency].
    Yabuta K
    Nihon Rinsho; 1989 Jul; 47(7):1646-8. PubMed ID: 2509763
    [No Abstract]   [Full Text] [Related]  

  • 38. Renal tubular acidosis.
    Morris RC
    N Engl J Med; 1981 Feb; 304(7):418-20. PubMed ID: 7453756
    [No Abstract]   [Full Text] [Related]  

  • 39. Atypical manifestation of carnitine palmitoyltransferase 1A deficiency: hepatosplenomegaly and nephromegaly.
    Lee BH; Kim YM; Kim JH; Kim GH; Kim JM; Kim JH; Woo KH; Yang SH; Kim CJ; Choi IH; Yoo HW
    J Pediatr Gastroenterol Nutr; 2015 Mar; 60(3):e19-22. PubMed ID: 23969540
    [No Abstract]   [Full Text] [Related]  

  • 40. Carnitine palmitoyltransferase II deficiency in a prenatal case with polycystic kidney disease-like phenotype.
    He Y; Li DZ
    Congenit Anom (Kyoto); 2020 Jul; 60(4):131-132. PubMed ID: 31599017
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.